Verrukatsid, 2 g

Calluses, Warts

Common, thread warts, plantar warts, papillomas, acute condyloma of the skin, dry calluses, keratomas.

Indications

Common, filiform and plantar warts, papillomas, genital warts of the skin, dry calluses, keratomas.

Pharmacological effect

Verrukacid® has a cauterizing effect and coagulates skin proteins.

Special instructions

Avoid contact with healthy skin and mucous membranes (especially eyes). In case of contact with eyes, rinse them immediately with plenty of water and consult an ophthalmologist.

Do not bandage, tape or lubricate the treated areas with ointment, remove crusts, or reapply the drug before the specified time. It is necessary to ensure that the treated area dries in the air, to prevent its contact with clothing made of synthetic fabric, and not to wash it on the first day.

It is not recommended to apply Verrucacid to formations located in skin folds (inguinal folds, anal area, interdigital spaces, etc.) and heavily sweating areas, in order to avoid burns to unaffected skin.

If it is necessary to apply the drug repeatedly, in order to avoid burns to the surrounding skin, it is advisable to lubricate it with zinc paste. The paste is removed with a dry gauze swab after the last portion of Verrukacid has dried.

In case of accidental contact of the drug on healthy skin, it is necessary to immediately, carefully, without rubbing, remove it from the skin, and then treat the affected areas with 10–40% ethyl alcohol or alcohol-containing liquids (lotion, cologne) and wash thoroughly with warm water and soap.

If a burn occurs, it is recommended to use anti-burn and healing agents.

Particular care should be taken when using the drug in children.

Active ingredient

Phenol, Metacresol

Composition

Active substances:

Pregnancy

The use of the drug is possible in cases where the expected benefit to the mother outweighs the potential risk to the fetus or child. During lactation, it is not recommended to remove formations located on the mammary glands and hands.

Contraindications

Increased individual sensitivity to the components of the drug Verrukacid.

Pigmented nevi (moles), rashes located on the red border of the lips and mucous membranes.

Do not apply the drug to the surface of the skin with an area of ​​more than 20 cm2. Children under 7 years old.

Side Effects

Swelling and redness of the eyelid (when treating lesions near the eyes). It goes away on its own.

Interaction

The components of the drug easily dissolve in the ointment base, so it is not recommended to lubricate areas treated with Verrucacid with any ointments.

Overdose

Not identified.

Storage conditions

In a place protected from light, at a temperature of 18–22 °C

Shelf life

5 years

Manufacturer

Retinoids JSC, Russia